Ibex Technologies (STU:IBT) 3-Year Revenue Growth Rate : 11.20% (As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is Ibex Technologies 3-Year Revenue Growth Rate?

Ibex Technologies's Revenue per Share for the three months ended in Jan. 2024 was €0.05.

During the past 12 months, Ibex Technologies's average Revenue per Share Growth Rate was 2.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Ibex Technologies was 28.00% per year. The lowest was -58.40% per year. And the median was 3.80% per year.

Competitive Comparison of Ibex Technologies's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Ibex Technologies's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ibex Technologies's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's 3-Year Revenue Growth Rate falls into.

Ibex Technologies 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Ibex Technologies (STU:IBT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Ibex Technologies 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibex Technologies (STU:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (STU:IBT) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7

Website

https://www.ibex.ca

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (STU:IBT) Headlines

No Headlines